291 related articles for article (PubMed ID: 33519819)
1. Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation
Kim YI; Yi EJ; Kim YD; Lee AR; Chung J; Ha HC; Cho JM; Kim SR; Ko HJ; Cheon JH; Hong YR; Chang SY
Front Immunol; 2020; 11():609689. PubMed ID: 33519819
[TBL] [Abstract][Full Text] [Related]
2. MiR-155 contributes to intestinal barrier dysfunction in DSS-induced mice colitis via targeting HIF-1α/TFF-3 axis.
Liu Y; Zhu F; Li H; Fan H; Wu H; Dong Y; Chu S; Tan C; Wang Q; He H; Gao F; Leng X; Zhou Q; Zhu X
Aging (Albany NY); 2020 Jul; 12(14):14966-14977. PubMed ID: 32713852
[TBL] [Abstract][Full Text] [Related]
3. Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis.
Keely S; Campbell EL; Baird AW; Hansbro PM; Shalwitz RA; Kotsakis A; McNamee EN; Eltzschig HK; Kominsky DJ; Colgan SP
Mucosal Immunol; 2014 Jan; 7(1):114-23. PubMed ID: 23695513
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factor-1α-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.
Sun M; He C; Wu W; Zhou G; Liu F; Cong Y; Liu Z
Clin Exp Immunol; 2017 Mar; 187(3):428-440. PubMed ID: 27921309
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological HIF-1 stabilization promotes intestinal epithelial healing through regulation of α-integrin expression and function.
Goggins BJ; Minahan K; Sherwin S; Soh WS; Pryor J; Bruce J; Liu G; Mathe A; Knight D; Horvat JC; Walker MM; Keely S
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G420-G438. PubMed ID: 33470153
[TBL] [Abstract][Full Text] [Related]
6. The role of hypoxia-inducible factor 1-alpha in inflammatory bowel disease.
Yin J; Ren Y; Yang K; Wang W; Wang T; Xiao W; Yang H
Cell Biol Int; 2022 Jan; 46(1):46-51. PubMed ID: 34658125
[TBL] [Abstract][Full Text] [Related]
7. SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α.
Zhou C; Li L; Li T; Sun L; Yin J; Guan H; Wang L; Zhu H; Xu P; Fan X; Sheng B; Xiao W; Qiu Y; Yang H
J Mol Med (Berl); 2020 Aug; 98(8):1189-1202. PubMed ID: 32696223
[TBL] [Abstract][Full Text] [Related]
8. Regulation of IL-12p40 by HIF controls Th1/Th17 responses to prevent mucosal inflammation.
Marks E; Naudin C; Nolan G; Goggins BJ; Burns G; Mateer SW; Latimore JK; Minahan K; Plank M; Foster PS; Callister R; Veysey M; Walker MM; Talley NJ; Radford-Smith G; Keely S
Mucosal Immunol; 2017 Sep; 10(5):1224-1236. PubMed ID: 28120851
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factor hydroxylase inhibition enhances the protective effects of cyclosporine in colitis.
Halligan DN; Khan MN; Brown E; Rowan CR; Coulter IS; Doherty GA; Tambuwala MM; Taylor CT
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G90-G97. PubMed ID: 31070931
[TBL] [Abstract][Full Text] [Related]
10. Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.
Hindryckx P; De Vos M; Jacques P; Ferdinande L; Peeters H; Olievier K; Bogaert S; Brinkman B; Vandenabeele P; Elewaut D; Laukens D
J Immunol; 2010 Nov; 185(10):6306-16. PubMed ID: 20943999
[TBL] [Abstract][Full Text] [Related]
11. Oral delivery of prolyl hydroxylase inhibitor: AKB-4924 promotes localized mucosal healing in a mouse model of colitis.
Marks E; Goggins BJ; Cardona J; Cole S; Minahan K; Mateer S; Walker MM; Shalwitz R; Keely S
Inflamm Bowel Dis; 2015 Feb; 21(2):267-75. PubMed ID: 25545377
[TBL] [Abstract][Full Text] [Related]
12. The neurotensin-HIF-1α-VEGFα axis orchestrates hypoxia, colonic inflammation, and intestinal angiogenesis.
Bakirtzi K; West G; Fiocchi C; Law IK; Iliopoulos D; Pothoulakis C
Am J Pathol; 2014 Dec; 184(12):3405-14. PubMed ID: 25307345
[TBL] [Abstract][Full Text] [Related]
13. Induction of CD36 and thrombospondin-1 in macrophages by hypoxia-inducible factor 1 and its relevance in the inflammatory process.
Ortiz-Masià D; Díez I; Calatayud S; Hernández C; Cosín-Roger J; Hinojosa J; Esplugues JV; Barrachina MD
PLoS One; 2012; 7(10):e48535. PubMed ID: 23119050
[TBL] [Abstract][Full Text] [Related]
14. Oxygen sensing in intestinal mucosal inflammation.
Flück K; Fandrey J
Pflugers Arch; 2016 Jan; 468(1):77-84. PubMed ID: 26206140
[TBL] [Abstract][Full Text] [Related]
15. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
16. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.
Robinson A; Keely S; Karhausen J; Gerich ME; Furuta GT; Colgan SP
Gastroenterology; 2008 Jan; 134(1):145-55. PubMed ID: 18166352
[TBL] [Abstract][Full Text] [Related]
17. Mutual regulation between butyrate and hypoxia-inducible factor-1α in epithelial cell promotes expression of tight junction proteins.
Yin J; Zhou C; Yang K; Ren Y; Qiu Y; Xu P; Xiao W; Yang H
Cell Biol Int; 2020 Jun; 44(6):1405-1414. PubMed ID: 32129567
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia.
Morote-Garcia JC; Rosenberger P; Nivillac NM; Coe IR; Eltzschig HK
Gastroenterology; 2009 Feb; 136(2):607-18. PubMed ID: 19105964
[TBL] [Abstract][Full Text] [Related]
19. Mucosal inflammation downregulates PHD1 expression promoting a barrier-protective HIF-1α response in ulcerative colitis patients.
Brown E; Rowan C; Strowitzki MJ; Fagundes RR; Faber KN; Güntsch A; Halligan DN; Kugler J; Jones F; Lee CT; Doherty G; Taylor CT
FASEB J; 2020 Mar; 34(3):3732-3742. PubMed ID: 31944416
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses.
Curtis VF; Ehrentraut SF; Campbell EL; Glover LE; Bayless A; Kelly CJ; Kominsky DJ; Colgan SP
FASEB J; 2015 Jan; 29(1):208-15. PubMed ID: 25326537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
